Bioventus Inc. (87) | Business Finance (14)
Browse by Subcategory
Recent Contracts
-
Asset Purchase Agreement, dated May 10, 2023, by and among Misonix, LLC, Solsys Medical, LLC, Bioventus LLC and LifeNet Health
(Filed With SEC on May 16, 2023)
-
Amendment No. 1 to Option and Equity Purchase Agreement, between the Company, CartiHeal (2009) Ltd. (CartiHeal), Elron Ventures Ltd. and ESOP Management and Trust Services Ltd.,...
(Filed With SEC on June 22, 2022)
-
Agreement and plan of merger, dated as of March 30, 2021, by and among Bioventus LLC, Bioness Inc., Perseus Intermediate, Inc., Perseus Merger Sub, Inc., Alfred E. Mann Living...
(Filed With SEC on March 31, 2021)
-
Registration Rights Agreement, dated February 16, 2021, by and among Bioventus Inc. and the Original LLC Owners
(Filed With SEC on February 17, 2021)
-
Assignment and Assumption Agreement, dated February 9, 2021, by and between Bioventus Inc. and Bioventus LLC
(Filed With SEC on February 10, 2021)
-
Amendment and Termination of the Bioventus Stock Plan, dated as of February 9, 2021
(Filed With SEC on February 10, 2021)
-
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement
(Filed With SEC on February 10, 2021)
-
Form of Stock Option Award Grant Notice and Stock Option Agreement
(Filed With SEC on February 10, 2021)
-
Form of Registration Rights Agreement, to be effective upon the closing of this offering
(Filed With SEC on February 10, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on February 4, 2021)
-
Form of 2021 Employee Stock Purchase Plan
(Filed With SEC on February 4, 2021)
-
Form of Registration Rights Agreement, to be effective upon the closing of this offering
(Filed With SEC on February 4, 2021)
-
Specimen Stock Certificate evidencing the shares of Class A common stock
(Filed With SEC on January 20, 2021)
-
Option and Equity Purchase Agreement, dated as of July 15, 2020, among Bioventus LLC, CartiHeal (2009) Ltd., the Securityholders set forth on Schedule 1.01(a) thereto, each of the...
(Filed With SEC on January 20, 2021)